Nano-hydroxyapatite With Potassium Nitrate in the Therapy of the Dental Sensitivity
Launched by UNIVERSITÀ DEGLI STUDI DI SASSARI · Sep 8, 2016
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
Study Design
The study will be a clinical randomized double-blind trial monocentric.
The sample will be divided into three groups with 35 patients each one.
TREATMENTS NOT ALLOWED
Patients enrolled in the study should not be submitted, for the whole duration of the trial, to local and systemic treatments for dentine hypersensitivity.
Randomization
The randomization process shall be made using a table randomly generated by a computer. The researchers will not be involved in the randomization process.
Data Recording
The study involves the assessment of the following parameters:
Durin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients will be considered suitable for the study if they had sensitive teeth showing abrasion, erosion, or recession with the exposure of the cervical dentine.
- Exclusion Criteria:
- • Teeth with subjective or objective evidence of carious lesions, pulpitis, restorations, premature contact, cracked enamel, active periapical infection, or which had received periodontal surgery or root-planning up to 6 months prior to the investigation will be excluded from the study.
- • Professional desensitizing therapy during the previous 3 months, or use of desensitizing toothpaste in the last 6 weeks.
- • Patients will be also excluded if they will be under significant medication that could interfere with pain perception (e.g., antidepressants, anti-inflammatory drugs, sedatives, and muscle relaxants).
About Università Degli Studi Di Sassari
Università degli Studi di Sassari is a prominent academic institution located in Sardinia, Italy, dedicated to advancing medical research and education. With a strong focus on innovative clinical trials, the university collaborates with multidisciplinary teams to explore cutting-edge therapies and interventions across various medical fields. Its commitment to scientific excellence is underscored by a robust framework for ethical research practices and patient safety, ensuring that all clinical studies align with international standards. The university aims to contribute significantly to the advancement of healthcare knowledge and the improvement of patient outcomes through rigorous research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sassari, , Italy
Patients applied
Trial Officials
Egle Milia, Prof
Principal Investigator
Università degli Studi di Sassari
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials